How much funding has Saegis Pharmaceuticals raised?

Saegis Pharmaceuticals has raised $30.0M in total funding, most recently a Series B round.

Who are Saegis Pharmaceuticals's investors?

Saegis Pharmaceuticals's investors include Jerel Davis, Technology Partners, Polaris Partners.

When was Saegis Pharmaceuticals founded?

Saegis Pharmaceuticals was founded in 1999.

Where is Saegis Pharmaceuticals headquartered?

Saegis Pharmaceuticals is headquartered in Half Moon Bay, California, United States.

What industry is Saegis Pharmaceuticals in?

Saegis Pharmaceuticals operates in Biotech, Healthcare.

How many employees does Saegis Pharmaceuticals have?

Saegis Pharmaceuticals has 1-10 employees.

Saegis Pharmaceuticals

Half Moon Bay, United States · Founded 1999 · $30.0M raised

Biotech

Healthcare

Headquarters: Half Moon Bay, California
Employees: 1–10
Founded: 1999
Business Model: B2B

Website: saegispharma.com
Total Funding: $30.0M
Last Round: $30.0M Series B
Rounds: 1

About

Saegis Pharmaceuticals was a clinical-stage CNS drug discovery company that developed small molecule therapeutics for behavioral and cognitive disorders including Alzheimer's-associated dementia, mild cognitive impairment, ADHD, and schizophrenia. The company's lead candidate, SGS518, was a novel 5HT6 serotonin receptor antagonist being evaluated for Cognitive Impairment Associated with Schizophrenia (CIAS). Saegis raised a total of approximately $30 million in venture funding before being acquired by Danish pharmaceutical company Lundbeck in 2006, which continued development of its CNS pipeline assets.

Summary

Saegis Pharmaceuticals is a Biotech company based in Half Moon Bay, United States, founded in 1999. It has raised $30.0M in total across 1 round. Investors include Jerel Davis, Technology Partners and Polaris Partners.